Arixtra In Dialysis Patients Food

facebook share image   twitter share image   pinterest share image   E-Mail share image

More about "arixtra in dialysis patients food"

USE OF FONDAPARINUX FOR CIRCUIT PATENCY IN HEMODIALYSIS PATIENTS
ウェブ 2012年11月16日 Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II. Nephrol Dial Transplant. 2005; 20 : 444 …
From ajkd.org
作成者 Grace Ho, Kori Leblanc, Kori Leblanc, Rita Selby, Rita Selby, Rita Selby, Robert Richardson, Robert ...
Publish Year 2013


SAFETY AND EFFICACY OF FONDAPARINUX IN RENAL IMPAIRMENT - PMC
ウェブ 2015年1月14日 Current evidence regarding safe and effective use of fondaparinux in moderate-to-severe renal impairment is still weak. We recommend using fondaparinux …
From ncbi.nlm.nih.gov
作成者 Mohammad H. Al-Shaer, Tarek Ibrahim
Publish Year 2015


TREATMENT OF THROMBOSIS WITH FONDAPARINUX (ARIXTRA) IN A ...
ウェブ Fondaparinux (Arixtra, Sanofi-Synthélabo), a synthetic pentasaccharide, is contraindicated in patients with compromised renal function as it is excreted via …
From pubmed.ncbi.nlm.nih.gov


ARIXTRA | EUROPEAN MEDICINES AGENCY
ウェブ 2023年7月14日 What is Arixtra? What is Arixtra used for? How is Arixtra used? How does Arixtra work? How has Arixtra been studied? What benefit has Arixtra shown …
From ema.europa.eu


CLINICAL EXPERIENCE WITH PROPHYLACTIC FONDAPARINUX IN CRITICALLY ...
ウェブ Empirical dose adjustments may be prudent in critically ill patients with renal dysfunction; however, the optimal fondaparinux dosage in this population remains unknown. Peak …
From pubmed.ncbi.nlm.nih.gov


FONDAPARINUX: DOSING AND ADVERSE EFFECTS - UPTODATE
ウェブ 2023年7月25日 INTRODUCTION. Fondaparinux (Arixtra) is a synthetic anticoagulant based on the pentasaccharide sequence that makes up the minimal antithrombin (AT) …
From uptodate.com


NOVEL FONDAPARINUX PROTOCOL FOR ANTICOAGULATION THERAPY IN ...
ウェブ 2023年1月13日 1 Citations. Metrics. Abstract. Introduction. The literature recommends against the use of fondaparinux in patients with kidney failure and dialysis as it may, …
From bmcpharmacoltoxicol.biomedcentral.com


USE OF FONDAPARINUX (ARIXTRA((R))) IN A DIALYSIS PATIENT WITH ...
ウェブ 2005年3月1日 Dialysis. Use of fondaparinux (ARIXTRA ( (R))) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II. Authors: Michael Haase. …
From researchgate.net


医療用医薬品 : アリクストラ (アリクストラ皮下注1.5MG 他)
ウェブ 2023年11月22日 Arixtra Injection サンドファーマ 3339400G1029 1303円/筒 処方箋医薬品 注) アリクストラ皮下注2.5mg Arixtra Injection サンドファーマ …
From kegg.jp


POPULATION PHARMACOKINETICS-PHARMACODYNAMICS OF ...
ウェブ 2021年8月19日 Data on the anti-Xa efficacy of fondaparinux in dialysis-dependent chronic kidney disease (DD-CKD) patients are scarce. This study characterizes the …
From link.springer.com


[PDF] USE OF FONDAPARINUX (ARIXTRA) IN A DIALYSIS PATIENT ...
ウェブ 2005年2月1日 Medicine. TLDR. Fondaparinux is used in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II, a synthetic selective inhibitor …
From semanticscholar.org


USE OF FONDAPARINUX (ARIXTRA) IN A DIALYSIS PATIENT WITH ...
ウェブ Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II.
From pubmed.ncbi.nlm.nih.gov


USE OF FONDAPARINUX AS AN ANTICOAGULANT DURING HEMODIALYSIS ...
ウェブ Our findings indicate that fondaparinux sodium at an intravenous dose of 2.5 mg can be used successfully as an anticoagulant during a 4-hour conventional hemodialysis …
From pubmed.ncbi.nlm.nih.gov


EATING DURING THE HEMODIALYSIS SESSION: A PRACTICE ...
ウェブ 2020年6月6日 1. Introduction. In-center nutrition practices vary considerably across dialysis facilities around the world. In a 2014 cross-sectional survey, 61 out of 73 …
From ncbi.nlm.nih.gov


758: FONDAPARINUX USE IN SEVERE RENAL IMPAIRMENT AND RENAL ...
ウェブ Fondaparinux dose, dosing frequency, and anti-Xa level monitoring are described. The prophylactic fondaparinux anti-Xa range is 0.39-0.5 mcg/mL per our laboratory assay. …
From journals.lww.com


PRESCRIBING INFORMATION ARIXTRA - FOOD AND DRUG ...
ウェブ patients undergoing hip fracture surgery. A total of 1,711 patients were randomized and 1,673 were treated. Patients ranged in age from 17-101 years (mean age 77 years) …
From accessdata.fda.gov


DRUG DOSING DURING CONTINUOUS RENAL REPLACEMENT THERAPIES
ウェブ Abstract. Continuous renal replacement therapies (CRRT) are used to manage fluid overload and/or renal failure. The continuous nature of the fluid and solute removal has …
From ncbi.nlm.nih.gov


FEEDING DURING DIALYSIS—RISKS AND UNCERTAINTIES - PMC
ウェブ 2017年6月19日 First, interventional studies show that eating during dialysis causes a clinically significant reduction in systemic blood pressure during the postprandial period …
From ncbi.nlm.nih.gov


ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ...
ウェブ Arixtra should be used with caution in patients who have an increased risk of haemorrhage, such as those with congenital or acquired bleeding disorders (eg. …
From ec.europa.eu


FOOD AND DRUG ADMINISTRATION - HIGHLIGHTS OF ...
ウェブ In patients with acute symptomatic DVT and in patients with acute symptomatic PE, the recommended dose of ARIXTRA is 5<50 mg (body weight kg), 7.5 mg (body weight 50 …
From accessdata.fda.gov


COMPARISON OF FONDAPARINUX AND ENOXAPARIN IN ACUTE ...
ウェブ 2006年4月6日 Fondaparinux (Arixtra, GlaxoSmithKline), a synthetic pentasaccharide, selectively binds antithrombin and causes rapid and predictable inhibition of factor Xa. …
From nejm.org


FONDAPARINUX THERAPY IN A HEMODIALYSIS PATIENT WITH HEPARIN ...
ウェブ 2010年7月1日 The dosage of fondaparinux sodium was further decreased to 2.5 mg daily and then to 2.5 mg every other day, leading to a drop in the antifactor Xa levels to 0.8 …
From academic.oup.com


Related Search